Advanced glycation endproducts - Role in pathology of diabetic complications

Diabetes Research and Clinical Practice

Volumn 67, Issue 1, 2005, Pages 3-21

  Ahmed, Nessar ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Advanced glycation endproducts; Aminoguanidine; Antioxidant; Diabetes mellitus; Glycation; Hyperglycaemia

Indexed keywords

ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR BLOCKER; ALAGEBRIUM; ALPHA TOCOPHEROL; AMINOGUANIDINE; ANALGESIC AGENT; ANTIOXIDANT; CERULOPLASMIN; FLAVONOID; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; KAEMPFEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MYELIN; N PHENACYLTHIAZOLIUM BROMIDE; NUCLEIC ACID; PARACETAMOL; PROTEIN; QUERCETIN; RECEPTOR ANTIBODY; RUTOSIDE; SCAVENGER; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANEMIA; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; AUTOOXIDATION; CATARACT; CELL TYPE; CHEMICAL STRUCTURE; CLINICAL TRIAL; CONGENITAL MALFORMATION; CROSS LINKING; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; EMBRYOPATHY; FLU LIKE SYNDROME; FLUORESCENCE; GASTROINTESTINAL SYMPTOM; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; INFLAMMATION; MATERNAL DIABETES MELLITUS; MEDIATOR RELEASE; NONHUMAN; PROTEIN GLYCOSYLATION; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING IMPAIRMENT;

ANIMALS; ANTIOXIDANTS; DIABETES COMPLICATIONS; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; RECEPTORS, IMMUNOLOGIC;

EID: 11144324314     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.09.004     Document Type: Review

References (100)

1. UKPDS, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33, Lancet 352 (1998) 837-851.
2. I. Giardino, D. Edelstein, and M. Brownlee Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity: A model for intracellular glycosylation in diabetes J. Clin. Invest. 94 1994 110 117
3. C. Cerami, H. Founds, I. Nicholl, T. Mitsuhashi, D. Giordano, and S. Vanpatten Tobacco smoke is a source of toxic reactive glycation products Proc. Natl. Acad. Sci. U.S.A. 94 1997 13915 13920
4. D.R. McCance, D.G. Dyer, J.A. Dunn, K.E. Bailie, S.R. Thorpe, and J.W. Baynes Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus J. Clin. Invest. 91 1993 2470 2478
5. H. Obayashi, K. Nakano, H. Shigeta, M. Yamaguchi, K. Yoshimori, and M. Fukui Formation of crossline as a fluorescent advanced glycation endproduct in vitro and in vivo Biochem. Biophys. Res. Commun. 226 1996 37 41
6. E.B. Frye, T.P. Degenhardt, S.R. Thorpe, and J.W. Baynes Role of the Maillard reaction in aging of tissue proteins J. Biol. Chem. 273 1998 18714 18719
7. J.G. Farmer, P.C. Ulrich, and A. Cerami Novel pyrroles from sulfite-inhibited Maillard reactions: insights into the mechanism of inhibition J. Org. Chem. 53 1988 2346 2349
8. Y. Al-Abed, and R. Bucala Structure of a synthetic glucose derived advanced glycation endproduct that is immunologically cross-reactive with its naturally occurring counterparts Bioconjugate Chem. 11 2000 39 45
9. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.-D. Yan, and D. Stern Advanced Maillard reaction products are associated with Alzheimer disease pathology Proc. Natl. Acad. Sci. USA. 91 1994 5710 5714
10. ε-(Carboxymethyl)lysine is a dominant advanced glycation endproduct (AGE) in tissue proteins Biochemistry 34 1995 10872 10878
11. D.G. Dyer, J.A. Dunn, S.R. Thorpe, K.E. Bailie, T.J. Lyons, and D.R. McCance Accumulation of Maillard reaction products in skin collagen in diabetes and aging J. Clin. Invest. 91 1993 2463 2469
12. J. Miura, S. Yamagishi, Y. Uchigata, M. Takeuchi, H. Yamamoto, and Z. Makita Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with type 1 diabetes J. Diabetes Complications 17 2003 16 21
13. R.D.G. Leslie, H. Beyan, P. Sawtell, B.O. Boehm, T.D. Spector, and H. Snieder Level of an advanced glycated endproduct is genetically determined: a study of normal twins Diabetes 52 2003 2441 2444
14. S.P. Wolff, and R.T. Dean Glucose autoxidation and protein modification: the potential role of "autoxidative glycosylation" in diabetes mellitus Biochem. J. 245 1987 243 250
15. J.W. Baynes Role of oxidative stress in development of complications in diabetes Diabetes 40 1991 405 412
16. J.V. Hunt, M.A. Bottoms, and M.J. Mitchinson Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation Biochem. J. 291 1993 529 535
17. H.F. Bunn, and P.J. Higgins Reaction of monosaccharides with proteins: possible evolutionary significance Science 213 1981 222 224
18. B.S. Szwergold, F. Kappler, and T.R. Brown Identification of fructose-3-phosphate in the lens of diabetic rats Science 247 1990 451 454
19. J.W. Baynes The Maillard hypothesis on aging: time to focus on DNA Annal. N.Y. Acad. Sci. 959 2002 360 367
20. P.J. Thornalley, M. Westwood, T.W. Lo, and A.C. McLellan Formation of methylglyoxal-modified proteins in vitro and in vivo and their involvement in AGE-related processes Contributions Nephrol. 112 1995 24 31
21. P.J. Thornalley, A. Langborg, and H.S. Minhas Formation of glyoxal, methylglyoxal and 3-DG in the glycation of proteins Biochem. J. 344 1999 109 116
22. H. Vlassara, and M.R. Palace Diabetes and advanced glycation endproducts J. Intern. Med. 251 2002 87 101
23. Z. Turk, S. Ljubic, N. Turk, and B. Benko Detection of autoantibodies against advanced glycation endproducts and AGE-immune complexes in serum of patients with diabetes mellitus Clin. Chim. Acta 303 2001 105 115
24. H. Vlassara Advanced glycation endproducts and atherosclerosis Annal. Med. 28 1996 419 426
25. D.M. Stern, S.D. Yan, S.F. Yan, and A.-M. Schmidt Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes Age Res. Rev. 1 2002 1 15
26. ε-(Carboxymethyl)lysine modifications of proteins are ligands for RAGE that activate cell signaling pathways and modulate gene expression J. Biol. Chem. 274 1999 31740 31749
27. B.I. Hudson, L.G. Bucciarelli, T. Wendt, T. Sakaguchi, E. Lalla, and W. Qu Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders Arch. Biochem. Biophys. 419 2003 80 88
28. S. Yan, A.-M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, and Y.S. Zou Enhanced cellular oxidant stress by the interaction of advanced glycation endproducts with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897
29. A. Neumann, R. Schinzel, D. Palm, P. Riederer, and G. Munch High molecular weight hyaluronic acid acid inhibits advanced glycation endproduct induced NF-κB activation and cytokine expression FEBS Lett. 453 1999 283 287
30. A.W. Stitt The role of advanced glycation in the pathogenesis of diabetic retinopathy Exp. Mol. Pathol. 75 2003 95 108
31. R. Chibber, P.A. Molinatti, N. Rosatto, B. Lambourne, and E.V.M. Kohner Toxic action of advanced glycation endproducts on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy Diabetologia 40 1997 156 164
32. N. Tanaka, H. Yonekura, S. Yamagishi, H. Fjimori, Y. Yamamoto, and H. Yamamoto The receptor for advanced glycation endproducts is induced by the glycation products themselves and tumour necrosis factor-α through nuclear factor-κB, and by 17 β-estradiol through Sp-1 in human vascular endothelial cells J. Biol. Chem. 275 2000 25781 25790
33. S. Yamagishi, S. Amano, Y. Inagaki, T. Okamoto, K. Koga, and N. Sasaki Advanced glycation endproduct-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes Biochem. Biophys. Res. Commun. 290 2002 973 978
34. N. Nakamura, G. Hasegawa, H. Obayashi, M. Yamazaki, M. Ogata, and K. Nakano Increased concentration of pentosidine, an advanced glycation endproduct, and interleukin-6 in the vitreous of patients with proliferative diabetic retinopathy Diabetes Res. Clin. Practice 61 2003 93 101
35. N.H.M. Ansari, Y.L. Awasthi, and S.K. Srivastava Role of glycosylation in protein disulphide formation and cataractogenesis Exp. Eye Res. 31 1988 9 19
36. R.E. Perry, M.S. Swamy, and E.C. Abraham Progressive changes in lens crystalline glycation and high molecular weight aggregate formation leading to cataract development in streptozotocin-diabetic rats Exp. Eye Res. 44 1987 269 282
37. R. Cheng, B. Lin, K.W. Lee, and B.J. Ortwerth Similarity of the yellow chromophores isolated from human cataracts with those from ascorbic acid-modified calf lens proteins: evidence for ascorbic acid glycation during cataract formation Biochim. Biophys. Acta 1537 2001 14 26
38. A. Stevens The contribution of glycation to cataract formation in diabetes J. Am. Optom. Assoc. 69 1998 519 530
39. M.F. Lopes-Virella, R.L. Klein, T.J. Lyons, H.C. Stevenson, and J.L. Witztum Glycosylation of LDL enhances cholesteryl ester synthesis in human monocyte-derived macrophages Diabetes 37 1988 550 557
40. R. Bucala, Z. Makita, G. Vega, S. Grundy, T. Koschinsky, and A. Cerami Modification of LDL by advanced glycation endproducts contribute to the dyslipidaemia of diabetes and renal insufficiency Proc. Natl. Acad. Sci. U.S.A. 91 1994 9441 9445
41. R. Bucala Lipid and lipoprotein modification by AGEs: role in atherosclerosis Exp. Physiol. 82 1997 327 337
42. P.B. Duell, J.F. Oram, and E.L. Bierman Nonenzymatic glycosylation of HDL and impaired HDL receptor mediated cholesterol efflux Diabetes 40 1991 377 384
43. C.C. Hedrick, S.R. Thorpe, M.-X. Fu, C.M. Harper, J. Yoo, and S.M. Kim Glycation impairs high-density lipoprotein function Diabetologia 43 2000 312 320
44. T. Niwa, T. Kaatsuzaki, S. Miyazaki, T. Miyazaki, Y. Ishizaki, and F. Hayase Immunohistochemical detection of imidazolone, a novel advanced glycation endproduct, in kidneys and aortas of diabetic patients J. Clin. Invest. 99 1997 1272 1280
45. M. Brownlee, H. Vlassara, and A. Cerami Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein Diabetes 34 1985 938 941
46. L. Park, K. Raman, K. Lee, Y. Lu, L. Ferran, and W.-S. Chow Suppression of accelerated diabetic atherosclerosis by soluble receptor for AGE (sRAGE) Nature Med. 4 1998 1025 1031
47. R.-Y. Lin, R.P. Choudhury, W. Cai, M. Lu, J.T. Fallon, and E.A. Fisher Dietary glycotoxins promote diabetic atherosclerosis in apolipoprotein E-deficient mice Atherosclerosis 168 2003 213 220
48. S. Sugiyama, T. Miyata, K. Horie, Y. Lida, M. Tsuyuki, and H. Tanaka Advanced glycation endproducts in diabetic nephropathy Nephrol. Dial. Transplant. 11 1996 91 94
49. V.M. Monnier, D.R. Sell, R.H. Nagaraj, S. Miyata, S. Grandhee, and P. Odetti Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging and uremia Diabetes 41 1992 36 41
50. E.Y. Skolnik, Z. Yang, Z. Makita, S. Radoff, S. Kirstein, and H. Vlassara Human, rat and mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy J. Exp. Med. 174 1991 931 938
51. H. Vlassara, L.J. Striker, S. Teichberg, H. Fuh, Y.M. Li, and M. Steffes Advanced glycosylation endproducts induce glomerular sclerosis and albuminuria in normal rats Proc. Natl. Acad. Sci. U.S.A. 91 1994 11704 11708
52. Z. Makita, R. Bucala, E.J. Rayfield, E.A. Friedman, A.M. Kaufman, and S.M. Korbet Diabetic-uremic serum advanced glycosylation endproducts are chemically reactive and resistant to dialysis therapy: role in mortality of uremia Lancet 343 1994 1519 1522
53. T.J. Berg, H.J. Bangstad, P.A. Torjesen, R. Osterby, R. Bucala, and K.F. Hanssen Advanced glycation endproducts in serum predict changes in the kidney morphology of patients with diabetes mellitus Metabolism 46 1997 661 665
54. T. Shimoike, T. Inoguchi, F. Umeda, H. Nawata, K. Kawano, and H. Ochi The meaning of serum levels of advanced glycosylation endproducts in diabetic nephropathy Metabolism 49 2000 1030 1035
55. R. Bucala, and H. Vlassara Advanced glycosylation endproducts in diabetic renal and vascular disease Am. J. Kidney Dis. 26 1995 875 888
56. N. Tanji, G.S. Markowitz, C. Fu, T. Kislinger, A. Taguchi, and M. Pischetsrieder The expression of advanced glycation endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease J. Am. Soc. Nephrol. 11 2000 1656 1666
57. Y. Yamamoto, I. Kato, T. Doi, H. Yonekura, S. Ohashi, and M. Takeuchi Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice J. Clin. Invest. 108 2001 261 268
58. H. Stopper, R. Schinzel, K. Sebekova, and A. Heidland Genotoxicity of advanced glycation endproducts in mammalian cells Cancer Lett. 190 2003 151 156
59. H. Vlassara, M. Brownlee, and A. Cerami Recognition and uptake of human diabetic peripheral nerve myelin by macrophages Diabetes 34 1985 553 557
60. M. Brownlee, H. Vlassara, and A. Cerami Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitus Diabetes 35 1986 553 557
61. M. Brownlee Negative consequences of glycation Metabolism 49 2000 9 13
62. J.L. Mills, R.H. Knopp, J.L. Simpson, L. Jovanovic-Peterson, B.E. Metzger, and L.B. Holmes Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis N. Engl. J. Med. 318 1988 671 676
63. R.T. Gerber, K. Holemans, I. O'Brien-Coker, A.I. Mallet, R. Van Bree, and F.A. Van Assche Increase of the isoprostane 8-isoprostaglandin F (2α) in maternal and fetal blood of rats with streptozotocin-induced diabetes: evidence of lipid peroxidation Am. J. Obstet. Gynecol. 183 2000 1035 1040
64. U.J. Eriksson, P. Wentzel, H.S. Minhas, and P.J. Thornalley Teratogenicity of 3-deoxyglucosone and diabetic embryopathy Diabetes 47 1998 1960 1966
65. A. Gugliucci, and M. Bendayan Histones from diabetic rats contain increased levels of advanced glycation endproducts Biochem. Biophys. Res. Commun. 212 1995 56 62
66. M.T. Goova, J. Li, T. Kislinger, W. Qu, L.G. Bucciarelli, and S. Nowygrod Blockade of receptors for advanced glycation endproducts restores effective wound healing in diabetic mice Am. J. Pathol. 159 2001 513 525
67. 2-microglobulin modified with advanced glycation endproducts modulates collagen synthesis by human fibroblasts Kidney Int. 53 1998 1365 1373
68. R.B. Santana, L. Xu, H.B. Chase, S. Amar, D.T. Graves, and P.C. Trackman A role for advanced glycation endproducts in diminished bone healing in type 1 diabetes Diabetes 52 2003 1502 1510
69. M. Peppa, H. Brem, P. Ehrlich, J.-G. Zhang, W. Cai, and Z. Li Adverse effects of dietary glycotoxins on wound healing in genetically diabetic mice Diabetes 52 2003 2805 2813
70. M. Okumura, T. Okuda, T. Nakamura, and M. Yajima Acceleration of wound healing in diabetic mice by basic fibroblast growth factor Biol. Pharm. Bull. 19 1996 530 535
71. Y. Duraisamy, M. Slevin, N. Smith, J. Bailey, J. Zweit, and C. Smith Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes Angiogenesis 4 2001 277 288
72. F. Hata, N. Igaki, T. Nakamichi, S. Masuda, S. Nishimoto, and M. Oimomi Suppressive effect of α-ketogluteraldehyde dehydrogenase on the advanced process of the Maillard reaction Diabetes Res. Clin. Practice 5 1988 5413
73. H. Vlassara, M. Brownlee, and A. Cerami Specific macrophage receptor activity for advanced glycosylation endproducts inversely correlates with insulin levels in vivo Diabetes 37 1988 456 461
74. E. Cotlier Aspirin effect on cataract formation in patients with rheumatoid arthritis alone or combined with diabetes Int. Ophthalmol. 3 1981 173 177
75. R. Blakytney, and J.J. Harding Prevention of cataract in diabetic rats by aspirin, paracetamol (acetaminophen) and ibuprofen Exp. Eye Res. 54 1992 509 518
76. M.-X. Fu, S.R. Thorpe, and J.W. Baynes Effects of aspirin on glycation, glycoxidation and cross-linking of collagen T.P. Labuza G.A. Reineccius V.M. Monnier J.O. O'Brien J.W. Baynes Maillard Reactions in Chemistry, Food, and Health 1994 The Royal Society of Chemistry Cambridge 95 100
77. P.J. Thornalley Use of aminoguanidine (pimagedine) to prevent the formation of advanced glycation endproducts Arch. Biochem. Biophys. 419 2003 31 40
78. B.S. Lewis, and J.J. Harding The effects of aminoguanidine on the glycation (non-enzymic glycosylation) of lens protein Exp. Eye Res. 50 1990 463 467
79. D. Edelstein, and M. Brownlee Mechanistic studies of advanced glycosylation endproduct inhibition by aminoguanidine Diabetes 41 1992 26 29
80. P. Ou, and S.P. Wolff Aminoguanidine: a drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro Biochem. Pharmacol. 46 1993 1139 1144
81. E.N. Ellis, and B.H. Good Prevention of glomerular basement membrane thickening by aminoguanidine in experimental diabetes mellitus Metabolism 40 1991 1016 1019
82. T. Soulis, M.E. Cooper, D. Vranes, R. Bucala, and G. Jerums Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment Kidney Int. 50 1996 627 634
83. Y. Miyauchi, H. Shikama, T. Takasu, H. Okamiya, M. Umeda, and E. Hirasaki Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozotocin-induced diabetic rats Eur. J. Endocrinol. 134 1996 467 473
84. A.M. Birrell, S.J. Heffernan, A.D. Ansselin, S. Mclennan, D.K. Church, and A.G. Gillari Functional and structural abnormalities in the nerves of type 1 diabetic baboons: aminoguanidine does not improve nerve function Diabetologia 43 2000 110 116
85. H.P. Hammes, S. Martin, K. Federlin, K. Geisen, and M. Brownlee Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy Proc. Natl. Acad. Sci. U.S.A. 88 1991 11555 11558
86. R. Chibber, P.A. Molinatti, J.S.K. Wong, D. Mirlees, and E.V.M. Kohner The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillary pericytes Diabetes 43 1994 758 763
87. Z. Makita, H. Vlassara, E. Rayfield, K. Cartwright, E. Friedman, and R. Rodby Haemoglobin-AGE: a circulating marker of advanced glycosylation Science 258 1992 651 653
88. P. Raskin, D. Caltran, M. William, J.-P. Wuerth, and K. Cartwright Pimagedine reduces progression of retinopathy and lowers lipid levels in patients with type 1 diabetes mellitus J. Am. Soc. Nephrol. 10 1999 179A
89. G. Appel, K. Bolton, B. Freedman, J.-P. Wuerth, and K. Cartwright Pimagedine lowers total urinary protein and slows progression of overt diabetic nephropathy in patients with type 1 diabetes mellitus J. Am. Soc. Nephrol. 10 1999 153A
90. F. Whittier, B. Spinowitz, J.-P. Wuerth, and K. Cartwright Pimagedine safety profiles in patients with type 1 diabetes mellitus J. Am. Soc. Nephrol. 10 1999 184A
91. S. Vasan, X. Zhang, X. Zhang, A. Kapurniotu, J. Bernhagen, and S. Teichberg An agent cleaving glucose-derived protein cross-links in vitro and in vivo Nature 382 1996 275 278
92. M.E. Cooper, V. Thallas, J. Forbes, E. Scalbert, S. Sastra, and I. Darby The cross-link breaker, N-phenacylthiazolium bromide prevents vascular advanced glycation endproduct accumulation Diabetologia 43 2000 660 664
93. S. Yang, J.E. Litchfield, and J.W. Baynes AGE-breakers cleave model compounds, but do not break Maillard crosslinks in skin and tail collagen from diabetic rats Arch. Biochem. Biophys. 412 2003 42 46
94. S. Vasan, P. Foiles, and H. Founds Therapeutic potential of breakers of advanced glycation endproduct-protein crosslinks Arch. Biochem. Biophys. 419 2003 89 96
95. A. Ceriello, D. Giugliano, A. Quatraro, C. Donzella, G. Dipalo, and P.J. Lefebvre Vitamin E reduction of protein glycosylation in diabetes Diabetes Care 14 1991 68 72
96. I. Giardino, D. Edelstein, S. Horiuchi, N. Araki, and M. Brownlee Vitamin E prevents diabetes-induced formation of arterial wall intracellular advanced glycation endproducts Diabetes 44 1995 73A
97. 1c levels in poorly controlled diabetes Rev. Invest. Clin. 48 1996 421 424
98. J. Cerderberg, C.M. Siman, and U.J. Eriksson Combined treatment with vitamin E and vitamin C decreases oxidative stress and improves fetal outcome in experimental diabetic pregnancy Pediatr. Res. 49 2001 755 762
99. Y. Duraisamy, J. Gaffney, M. Slevin, C.A. Smith, K. Williamson, and N. Ahmed Aminosalicylic acid reduces the antiproliferative effect of hyperglycaemia, advanced glycation endproducts and glycated basic fibroblast growth factor in cultured bovine aortic endothelial cells: comparison with aminoguanidine Mol. Cellular Biochem. 246 2003 143 153
100. S. Asgary, G. Naderi, N. Sarrafzadegan, N. Ghassemi, M. Boshtam, and M. Rafie Anti-oxidant effect of flavonoids on haemoglobin glycosylation Pharma. Acta Helvetiae 73 1999 223 226